Sermonix Pharmaceuticals Announces Poster Presentation at
Poster describes pre-clinical findings that lasofoxifene alone or in combination with a CDK inhibitor may limit tumor progression in aromatase inhibitor...
Source: globenewswire.com
Stay updated with breaking news from 021 Sabcs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Poster describes pre-clinical findings that lasofoxifene alone or in combination with a CDK inhibitor may limit tumor progression in aromatase inhibitor...